Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (11)

« Back to Publications

Evaluating video and hybrid group consultations in general practice: mixed-methods, participatory study protocol (TOGETHER 2)

Papoutsi C. et al, (2024), NIHR Open Research, 4

Training needs for staff providing remote services in general practice: a mixed-methods study.

Greenhalgh T. et al, (2024), Br J Gen Pract, 74, e17 - e26

Using Patient Perspectives to Inform Better Clinical Trial Design and Conduct: Current Trends and Future Directions.

Faulkner SD. et al, (2023), Pharmaceut Med, 37, 129 - 138

Pharmaceutical Company Targets and Strategies to Address Climate Change: Content Analysis of Public Reports from 20 Pharmaceutical Companies.

Booth A. et al, (2023), Int J Environ Res Public Health, 20

Optimising Multi-stakeholder Practices in Patient Engagement: A Gap Analysis to Enable Focused Evolution of Patient Engagement in the Development and Lifecycle Management of Medicines.

Faulkner SD. et al, (2021), Ther Innov Regul Sci, 55, 1165 - 1179

Sustaining Meaningful Patient Engagement Across the Lifecycle of Medicines: A Roadmap for Action.

Cavaller-Bellaubi M. et al, (2021), Ther Innov Regul Sci, 55, 936 - 953

Understanding multi-stakeholder needs, preferences and expectations to define effective practices and processes of patient engagement in medicine development: A mixed-methods study.

Faulkner SD. et al, (2021), Health Expect, 24, 601 - 616

Medicines Adaptive Pathways to Patients: Why, When, and How to Engage?

Eichler H-G. et al, (2019), Clin Pharmacol Ther, 105, 1148 - 1155

Pricing and reimbursement experiences and insights in the European Union and the United States: Lessons learned to approach adaptive payer pathways.

Faulkner SD. et al, (2016), Clin Pharmacol Ther, 100, 730 - 742

n assessment of implications of adaptive licensing for pharmaceutical intellectual property and regulatory exclusivity rights in the European Union.

Meier A. et al, (2016), Clin Pharmacol Ther, 100, 743 - 753

Brain mitochondrial oxidative metabolism during and after cerebral hypoxia-ischemia studied by simultaneous phosphorus magnetic-resonance and broadband near-infrared spectroscopy.

Bainbridge A. et al, (2014), Neuroimage, 102 Pt 1, 173 - 183